Bruchovsky N - Search Results

1

[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma].

Bruchovsky N, Goldenberg SL, Rennie PS, Gleave M. Bruchovsky N, et al. Urologe A. 1995 Sep;34(5):389-92. Urologe A. 1995. PMID: 7483155 Review. German.

2

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parameters.

Bruchovsky N, Klotz L, Crook J, Malone S, Ludgate C, Morris WJ, Gleave ME, Goldenberg SL. Bruchovsky N, et al. Cancer. 2006 Jul 15;107(2):389-95. doi: 10.1002/cncr.21989. Cancer. 2006. PMID: 16783817 Free article. Clinical Trial.

3

Locally advanced prostate cancer--biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.

Bruchovsky N, Klotz L, Crook J, Goldenberg SL. Bruchovsky N, et al. Cancer. 2007 Mar 1;109(5):858-67. doi: 10.1002/cncr.22464. Cancer. 2007. PMID: 17265527 Free article. Clinical Trial.

4

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D. Bruchovsky N, et al. Cancer Res. 1990 Apr 15;50(8):2275-82. Cancer Res. 1990. PMID: 2317815

5

The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.

Goldenberg SL, Bruchovsky N, Rennie PS, Coppin CM. Goldenberg SL, et al. Among authors: bruchovsky n. J Urol. 1988 Dec;140(6):1460-5. doi: 10.1016/s0022-5347(17)42073-8. J Urol. 1988. PMID: 2973529

6

Relationship of androgen receptors to the growth and regression of the prostate.

Rennie PS, Bruchovsky N, Goldenberg SL. Rennie PS, et al. Among authors: bruchovsky n. Am J Clin Oncol. 1988;11 Suppl 2:S13-7. doi: 10.1097/00000421-198801102-00004. Am J Clin Oncol. 1988. PMID: 3071950 Review.

7

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.

Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Gleave ME, et al. Among authors: bruchovsky n. J Urol. 1996 Jan;155(1):213-9. J Urol. 1996. PMID: 7490838 Clinical Trial.

8

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.

Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD, Akakura K. Goldenberg SL, et al. Among authors: bruchovsky n. Urology. 1995 May;45(5):839-44; discussion 844-5. doi: 10.1016/s0090-4295(99)80092-2. Urology. 1995. PMID: 7538246 Clinical Trial.

9

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.

Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Akakura K, et al. Among authors: bruchovsky n. Cancer. 1993 May 1;71(9):2782-90. doi: 10.1002/1097-0142(19930501)71:9<2782::aid-cncr2820710916>3.0.co;2-z. Cancer. 1993. PMID: 7682149

10

Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.

Bruchovsky N, Goldenberg SL, Akakura K, Rennie PS. Bruchovsky N, et al. Cancer. 1993 Sep 1;72(5):1685-91. doi: 10.1002/1097-0142(19930901)72:5<1685::aid-cncr2820720532>3.0.co;2-3. Cancer. 1993. PMID: 7688656 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters